Evidence that rat stomach ECL cells represent the main source of circulating pancreastatin

Regulatory Peptides

Volumn 68, Issue 3, 1997, Pages 177-180

  Kimura, Keizo ^a   Chen, Duan ^a   Lindström, Erik ^a   Zhao, Chun Mei ^a   Håkanson, Rolf ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

ECL cell; Fundectomy; Gastrin; Omeprazole; Pancreastatin

Indexed keywords

GASTRIN; HISTIDINE DECARBOXYLASE; OMEPRAZOLE; PANCREASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH ACID SECRETION; STOMACH PARIETAL CELL;

ANIMALIA;

EID: 0031586737     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)02117-9     Document Type: Article

References (26)

1. Winkler, H. and Fischer-Colbrie, R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience, 49 (1992) 497-528.
2. Rindi G., Buffa, R., Sessa, F., Tortora O. and Solcia E. Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with the argyrophil component of secretory granules. Histochemistry, 85 (1986) 19-28.
3. Helle, K.B., Serck-Hanssen, G. and Aardal, S. Functional aspects of the adrenal medullary chromogranins. Neurochem. Int., 22 (1993) 353-360.
4. Curry, W.J., Johnston, C.F., Shaw, C. and Buchanan, K.D. Distribution and partial characterization of immunoreactivity to the putative C-terminus of rat pancreastatin. Regul. Pept., 30 (1990) 207-219.
5. Curry, W.J., Johnston, C.F., Hutton, J.C., Arden, S.D., Rutherford, N.G., Shaw C. and Buchanan, K.D. The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera. Histochemistry, 96 (1991) 531-538.
6. Watkinson A. and Dockray, G.J. Functional control of chromogranin A and B concentrations in the body of the rat stomach. Regul. Pept., 40 (1992) 51-61.
7. Chen D., Monstein, H-J., Nylander, A-G., Zhao, C-M., Sundler, F. and Håkanson, R. Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation. Gastroenterology, 107 (1994) 18-27.
8. Håkanson, R., Ding, X-Q., Norlén, P. and Chen, D. Circulating pancreastatin is a marker for the enterochromaffin-like cells of rat stomach. Gastroenterology, 108 (1995) 1445-1452.
9. Havu, N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35 (1986) (Suppl 1) 42-55.
10. Håkanson, R. and Sundler, F. Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis. Eur. J. Clin. Invest., 20 (1990)(Suppl 1) 65-71.
11. Larsson, H., Carlsson, E., Mattsson, H., Lundell, L., Sundler, F., Sundell, G., Wallmark, B., Watanabe, T. and Håkanson, R. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology, 90 (1986) 391-399.
12. Stadil, F. and Rehfeld, J. Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand. J. Gastroenterol., 8 (1973) 101-112.
13. Larsson, H., Carlsson, E., Mattsson, H., Lundell, L., Sundler, F., Sundell, G., Wallmark, B., Watanabe, T. and Håkanson, R. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology, 90 (1986) 391-399.
14. Sternberger, L.A. The unlabelled antibody peroxidase-antiperoxidase (PAP) method. In: L.A. Sternberger (Ed.), Immunocytochemistry, 2nd ed. Wiley, New York, 1979, pp. 104-169.
15. O'Connor, D.T. Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum. Regul. Pept., 6 (1983) 263-280.
16. Blaschko, H., Comline, R.S., Schneider, F.H., Silver, M. and Smith, A.D. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature, 215 (1967) 58-59.
17. Fischer-Colbrie, R., Hagn, C. and Schober, M. Chromogranins A, B and C: widespread constituents of secretory vesicles. Ann. NY Acad. Sci., 493 (1987) 120-134.
18. Bishop, A.E., Bretherton-Watt, D., Hamid, Q.A., Fahey, M., Shepherd, N., Valentino, K., Tatemoto, K., Ghatei, M.A., Bloom, S.R. and Polak, J.M. The occurrence of pancreastatin in tumors of the diffuse neuroendocrine system. Mol. Cell Probes, 2 (1988) 225-235.
19. Syversen, U., Waldum, H.L. and O'Connor, D.T. Rapid high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas. Neuropeptides, 22 (1992) 235-240.
20. Syversen, U., Jacobsen, M.B., O'Connor, D.T., Rønning, K. and Waldum, H.L. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Neuropeptides, 26 (1994) 201-206.
21. Eriksson, B., Arnberg, H., Öberg, K., Hellman, U., Lundqvist, G., Wernstedt, C. and Wilander, E. Chromogranins - new sensitive markers for neuroendocrine tumors. Acta Oncol., 28 (1989) 325-329.
22. Takiyyuddin, M.A., Barbosa, J.A., Hsiao, R.J., Parmer, R.J. and O'Connor, D.T. Diagnostic value of chromogranin A measured in the circulation. In: M. Gratzl and K. Langley (Eds.), Markers for Neural and Endocrine Cells, VCH, Weinheim, 1991, 191-201.
23. McGrath-Linden, S.J., Johnston, C.F., O'Connor, D.T., Shaw, C. and Buchanan, K.D. Pancreastatin-like immunoreactivity in human carcinoid disease. Regul. Pept., 33 (1991) 55-70.
24. Weiler, R., Feichtinger, H., Schmid, K.W., Fischer-Colbrie, R., Grimelius, L., Cedermark, B., Papotti, M., Bussolati, G. and Winkler, H. Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids. Virchows Arch. (A) Anat., 412 (1987) 103-109.
25. Stabile, B.E., Howard, T.J., Passaro, E. and O'Connor, D.T. Source of plasma chromogranin A elevation in gastrinoma patients. Arch. Surg., 125 (1990) 451-453.
26. Syversen, U., Mignon, M., Bonfils, S., Kristensen, A. and Waldum, H.L. Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol., 32 (1993) 161-165.